Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

62.98
Delayed Data
As of Nov 27
 +5.96 / +10.45%
Today’s Change
19.51
Today|||52-Week Range
73.72
-0.71%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues382.0K158.3K31.4M16.1M
 
 
 
 
 
Depreciation And Amortization2.3M3.3M4.7M4.7M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses82.0M82.5M63.7M67.4M
 
 
 
 
 
Research And Development47.3M41.5M31.7M48.3M
 
 
 
 
 
Total Operating Expenses84.3M85.7M68.4M72.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-83.9M-85.6M-37.0M-55.9M
 
 
 
 
 
Extraordinary Credit2.9M5.9M2.2M432.1K
 
 
 
 
 
Extraordinary Charge-12.0M-2.4M0.000.00
 
 
 
Other Expenses437.1K57.4K0.007.5K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-91.9M-81.7M-34.4M-54.4M
 
 
 
 
 
Income Taxes-2.4K-2.4K-2.4K-2.4K
 
 
 
 
 
Net Income-91.9M-81.7M-34.4M-54.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS57.4M61.1M73.9M83.6M
 
 
 
 
 
Shares To Calculate EPS Diluted57.4M61.1M73.9M83.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.60-$1.34-$0.47-$0.65
 
 
 
 
 
EPS Diluted-$1.60-$1.34-$0.47-$0.65